Zalifrelimab

Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling.
Read more
€0.00 (tax incl.)
Reference:
HY-P99514
Product Details
HY-P99514

Data sheet

Size
Multiple sizes
Reactivity
CTLA-4
Application
Cancer-programmed cell death
CAS
2148321-69-9

Menu

Settings